Curated Wealth Partners LLC reduced its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 99.5% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,357 shares of the financial services provider's stock after selling 655,278 shares during the period. Curated Wealth Partners LLC's holdings in CME Group were worth $879,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. BlackRock Inc. acquired a new stake in shares of CME Group during the 2nd quarter worth approximately $6,749,965,000. Bank of New York Mellon Corp bought a new stake in shares of CME Group in the 2nd quarter worth approximately $867,313,000. Alphabet Inc. bought a new stake in shares of CME Group in the 2nd quarter worth approximately $769,376,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of CME Group in the 2nd quarter worth approximately $629,771,000. Finally, Bank of America Corp DE bought a new stake in shares of CME Group in the 2nd quarter worth approximately $622,679,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at CME Group
In other CME Group news, Director Elizabeth A. Cook sold 500 shares of the business's stock in a transaction on Monday, September 14th. The stock was sold at an average price of $280.11, for a total transaction of $140,055.00. Following the completion of the transaction, the director owned 17,916 shares in the company, valued at approximately $5,018,450.76. The trade was a 2.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 15,000 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $274.44, for a total value of $4,116,600.00. Following the completion of the transaction, the chief executive officer directly owned 40,630 shares of the company's stock, valued at approximately $11,150,497.20. The trade was a 26.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by company insiders.
CME Group Stock Performance
CME opened at $289.46 on Friday. The business's 50 day moving average is $273.52 and its 200-day moving average is $270.60. The stock has a market cap of $104.08 billion, a PE ratio of 24.55, a price-to-earnings-growth ratio of 3.74 and a beta of 0.24. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%. The business had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the firm posted $2.96 earnings per share. The business's revenue was up .8% on a year-over-year basis. On average, analysts predict that CME Group Inc. will post 12.29 earnings per share for the current year.
CME Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Wednesday, September 9th were given a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.8%. The ex-dividend date was Wednesday, September 9th. CME Group's dividend payout ratio (DPR) is currently 44.11%.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft lowered CME Group from a "buy" rating to a "hold" rating and reduced their price objective for the company from $286.00 to $270.00 in a research report on Wednesday, August 19th. JPMorgan Chase & Co. increased their target price on CME Group from $249.00 to $250.00 and gave the stock an "underweight" rating in a research report on Thursday, July 23rd. UBS Group increased their target price on CME Group from $260.00 to $270.00 and gave the stock a "neutral" rating in a research report on Monday, October 5th. Wall Street Zen upgraded CME Group from a "strong sell" rating to a "sell" rating in a research note on Saturday, October 3rd. Finally, Raymond James Financial reissued an "outperform" rating and set a $320.00 price target on shares of CME Group in a report on Thursday, July 2nd. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $292.94.
View Our Latest Stock Analysis on CME
CME Group Company Profile
(
Free Report)
CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.
The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.
CME Group's history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.
Further Reading
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.